001     856101
005     20210129235234.0
024 7 _ |a 10.1039/C8CC01458B
|2 doi
024 7 _ |a 0009-241X
|2 ISSN
024 7 _ |a 0022-4936
|2 ISSN
024 7 _ |a 1359-7345
|2 ISSN
024 7 _ |a 1364-548X
|2 ISSN
024 7 _ |a 2050-5620
|2 ISSN
024 7 _ |a 2050-5639
|2 ISSN
024 7 _ |a pmid:29537428
|2 pmid
024 7 _ |a WOS:000428553500024
|2 WOS
024 7 _ |a altmetric:33888048
|2 altmetric
037 _ _ |a FZJ-2018-05747
082 _ _ |a 540
100 1 _ |a Cavini, Italo A.
|0 0000-0003-2035-6584
|b 0
245 _ _ |a Inhibition of amyloid Aβ aggregation by high pressures or specific D-enantiomeric peptides
260 _ _ |a Cambridge
|c 2018
|b Soc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1539237133_30019
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Pressure can shift the polymer–monomer equilibrium of Aβ, increasing pressure first leads to a release of Aβ-monomers, surprisingly at pressures higher than 180 MPa repolymerization is induced. By high pressure NMR spectroscopy, differences of partial molar volumes ΔV0 and compressibility factors Δβ′ of polymerization were determined at different temperatures. The D-enantiomeric peptides RD2 and RD2D3 bind to monomeric Aβ with affinities substantially higher than those determined for fibril formation. By reducing the Aβ concentration below the critical concentration for polymerization they inhibit the formation of toxic oligomers. Chemical shift perturbation allows the identification of the binding sites. The D-peptides are candidates for drugs preventing Alzheimer's disease. We show that RD2D3 has a positive effect on the cognitive behaviour of transgenic (APPSwDI) mice prone to Alzheimer's disease. The heterodimer complexes have a smaller Stokes radius than Aβ alone indicating the recognition of a more compact conformation of Aβ identified by high pressure NMR before.
536 _ _ |a 553 - Physical Basis of Diseases (POF3-553)
|0 G:(DE-HGF)POF3-553
|c POF3-553
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Munte, Claudia E.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Erlach, Markus Beck
|0 P:(DE-HGF)0
|b 2
700 1 _ |a van Groen, Thomas
|0 0000-0002-1861-7530
|b 3
700 1 _ |a Kadish, Inga
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Zhang, Tao
|0 P:(DE-Juel1)174389
|b 5
700 1 _ |a Ziehm, Tamar
|0 P:(DE-Juel1)162487
|b 6
|u fzj
700 1 _ |a Nagel-Steger, Luitgard
|0 P:(DE-Juel1)162443
|b 7
|u fzj
700 1 _ |a Kutzsche, Janine
|0 P:(DE-Juel1)159137
|b 8
|u fzj
700 1 _ |a Kremer, Werner
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Willbold, Dieter
|0 P:(DE-Juel1)132029
|b 10
700 1 _ |a Kalbitzer, Hans Robert
|0 0000-0002-6514-2355
|b 11
|e Corresponding author
773 _ _ |a 10.1039/C8CC01458B
|g Vol. 54, no. 26, p. 3294 - 3297
|0 PERI:(DE-600)1472881-3
|n 26
|p 3294 - 3297
|t Chemical communications
|v 54
|y 2018
|x 1364-548X
856 4 _ |u https://juser.fz-juelich.de/record/856101/files/Inhibition%20of%20amyloid%20A%CE%B2%20aggregation%20by%20high%20pressures%20or%20specific%20D-enantiomeric%20peptides.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/856101/files/Inhibition%20of%20amyloid%20A%CE%B2%20aggregation%20by%20high%20pressures%20or%20specific%20D-enantiomeric%20peptides.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:856101
|p VDB
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 5
|6 P:(DE-Juel1)174389
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)162487
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 7
|6 P:(DE-Juel1)162443
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 8
|6 P:(DE-Juel1)159137
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 10
|6 P:(DE-Juel1)132029
913 1 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-553
|2 G:(DE-HGF)POF3-500
|v Physical Basis of Diseases
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2018
915 _ _ |a Allianz-Lizenz / DFG
|0 StatID:(DE-HGF)0400
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CHEM COMMUN : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CHEM COMMUN : 2017
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|k ICS-6
|l Strukturbiochemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-7-20200312


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21